These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 4369570

  • 1. [Further purification of Cl. perfringens hyaluronidase].
    Klimacheva LV, Ispolatovskaia MV.
    Vopr Med Khim; 1973; 19(6):641-4. PubMed ID: 4369570
    [No Abstract] [Full Text] [Related]

  • 2. [Isolation and various properties of Cl. perfringens hyaluronidase].
    Klimacheva LV, Ispolatovskaia MV.
    Vopr Med Khim; 1970; 16(4):381-6. PubMed ID: 4324119
    [No Abstract] [Full Text] [Related]

  • 3. [Effct of divalent cations on the production of hyaluronidase of Clostridium perfringens type A].
    Aleksandrowicz J, Mierzejewska H.
    Med Dosw Mikrobiol; 1967; 19(4):347-51. PubMed ID: 4295546
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of glucose and hyaluronic acid on hyaluronidase level in the supernatants of Clostridium perfringens type A].
    Meisel H, Aleksandrowicz J, Mierzejewska H.
    Med Dosw Mikrobiol; 1966; 18(4):361-7. PubMed ID: 4289228
    [No Abstract] [Full Text] [Related]

  • 5. Purification and characterization of tarantula, Dugesiella hentzi (Girard) venom hyaluronidase.
    Schanbacher FL, Lee CK, Wilson IB, Howell DE, Odell GV.
    Comp Biochem Physiol B; 1973 Feb 15; 44(2):389-96. PubMed ID: 4709583
    [No Abstract] [Full Text] [Related]

  • 6. Purification and characterization of alpha-N-acetylgalactosaminidase from Clostridium perfringens.
    Hsieh HY, Mitra M, Wells DC, Smith D.
    IUBMB Life; 2000 Aug 15; 50(2):91-7. PubMed ID: 11185964
    [Abstract] [Full Text] [Related]

  • 7. [Structure of blood group substances. Degradation of the (A + H) blood group substance by the action of an enzyme preparation of Clostridium perfringens].
    Kochetkov NK, Derevitskaia VA, Likhosherstov LM, Martynova MD.
    Dokl Akad Nauk SSSR; 1969 Jun 11; 186(5):1195-7. PubMed ID: 4319831
    [No Abstract] [Full Text] [Related]

  • 8. [Purification and characterization of streptococcal hyaluronate lyase (author's transl)].
    Ozegowski JH, Gerlach D, Köhler W.
    Zentralbl Bakteriol A; 1981 Aug 11; 249(3):310-22. PubMed ID: 7269855
    [Abstract] [Full Text] [Related]

  • 9. Purification and properties of hyaluronidase from Streptococcus mitis.
    Nord CE.
    Odontol Revy; 1971 Aug 11; 22(2):125-36. PubMed ID: 4948585
    [No Abstract] [Full Text] [Related]

  • 10. The detection of hyaluronidase on electrophoresis membranes.
    Herd JK, Tschida J, Motycka L.
    Anal Biochem; 1974 Sep 11; 61(1):133-43. PubMed ID: 4370443
    [No Abstract] [Full Text] [Related]

  • 11. Acceleration of hyaluronidase production in the course of batch cultivation of Clostridium perfringens can be achieved with bacteriolytic enzymes.
    Zukaite V, Biziulevicius GA.
    Lett Appl Microbiol; 2000 Mar 11; 30(3):203-6. PubMed ID: 10747251
    [Abstract] [Full Text] [Related]

  • 12. Purification and partial characterization of hyaluronidase from stonefish (Synanceja horrida) venom.
    Poh CH, Yuen R, Chung MC, Khoo HE.
    Comp Biochem Physiol B; 1992 Mar 11; 101(1-2):159-63. PubMed ID: 1499262
    [Abstract] [Full Text] [Related]

  • 13. [Morphological and some histochemical changes in the organism of guinea pigs caused by hyaluronidase from Cl. perfringens type A].
    Anosov IIa, Klimacheva LV.
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Sep 11; 48():133-6. PubMed ID: 4329698
    [No Abstract] [Full Text] [Related]

  • 14. Purification and characterization of a hyaluronidase associated with a temperate bacteriophage of group A, type 49 streptococci.
    Benchetrit LC, Gray ED, Edstrom RD, Wannamaker LW.
    J Bacteriol; 1978 Apr 11; 134(1):221-8. PubMed ID: 25884
    [Abstract] [Full Text] [Related]

  • 15. Purification of hyaluronidase from Clostridium perfringens.
    BAKER EM, WEBSTER ME, FREEMAN ME, CARY SG, SANDERS AC.
    Proc Soc Exp Biol Med; 1956 Jan 11; 91(1):24-7. PubMed ID: 13297698
    [No Abstract] [Full Text] [Related]

  • 16. [A study of the soluble antigens of strains of Cl. perfringens isolated from the feces of healthy persons].
    Goeva OE, Borovik EB, Sidorenko GI.
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May 11; 45(5):43-6. PubMed ID: 4308712
    [No Abstract] [Full Text] [Related]

  • 17. [Purification and some properties of Cl. perfringens lecithinase].
    Ispolatovskaia MV.
    Vopr Med Khim; 1971 May 11; 17(2):137-41. PubMed ID: 4325641
    [No Abstract] [Full Text] [Related]

  • 18. Purification and characterization of a recombinant alpha-N-acetylgalactosaminidase from Clostridium perfringens.
    Hsieh HY, Calcutt MJ, Chapman LF, Mitra M, Smith DS.
    Protein Expr Purif; 2003 Dec 11; 32(2):309-16. PubMed ID: 14965778
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic contaminants in commercial Clostridium perfringens neuraminidase preparations purified by affinity chromatography.
    Den H, Malinzak DA, Rosenberg A.
    J Chromatogr; 1975 Aug 20; 111(1):217-22. PubMed ID: 239961
    [No Abstract] [Full Text] [Related]

  • 20. A simple method for the purification of commercial neuraminidase preparations free from proteases.
    Hatton MW, Regoeczi E.
    Biochim Biophys Acta; 1973 Nov 15; 327(1):114-20. PubMed ID: 4358815
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.